6.
Wu L, Liu Y, Zhao Y, Li M, Guo L
. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Free Radic Biol Med. 2020; 153:140-158.
DOI: 10.1016/j.freeradbiomed.2020.04.009.
View
7.
Sabir U, Irfan H, Alamgeer , Ullah A, Althobaiti Y, Asim M
. Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach. J Inflamm Res. 2022; 15:1293-1316.
PMC: 8886028.
DOI: 10.2147/JIR.S354878.
View
8.
Santini S, Tarantino G, Iezzi A, Alisi A, Balsano C
. Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage. Nutr Metab (Lond). 2022; 19(1):9.
PMC: 8832663.
DOI: 10.1186/s12986-022-00641-z.
View
9.
Veskovic M, Mladenovic D, Milenkovic M, Tosic J, Borozan S, Gopcevic K
. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. Eur J Pharmacol. 2019; 848:39-48.
DOI: 10.1016/j.ejphar.2019.01.043.
View
10.
Becerril-Campos A, Ramos-Gomez M, De Los Rios-Arellano E, Ocampo-Anguiano P, Gonzalez-Gallardo A, Macotela Y
. Bean Leaves Ameliorate Lipotoxicity in Fatty Liver Disease. Nutrients. 2023; 15(13).
PMC: 10343741.
DOI: 10.3390/nu15132928.
View
11.
Zhang R, Yan Z, Zhong H, Luo R, Liu W, Xiong S
. Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment. Hepatol Commun. 2024; 8(7).
PMC: 11227362.
DOI: 10.1097/HC9.0000000000000484.
View
12.
Park S, Zhang T, Qiu J, Wu X
. The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats. Evid Based Complement Alternat Med. 2019; 2019:8063121.
PMC: 6582910.
DOI: 10.1155/2019/8063121.
View
13.
Faheem S, Saeed N, El-Naga R, Ayoub I, Azab S
. Hepatoprotective Effect of Cranberry Nutraceutical Extract in Non-alcoholic Fatty Liver Model in Rats: Impact on Insulin Resistance and Nrf-2 Expression. Front Pharmacol. 2020; 11:218.
PMC: 7093716.
DOI: 10.3389/fphar.2020.00218.
View
14.
Chenna H, Khelef Y, Halimi I, Yilmaz M, Cakir O, Djouder C
. Potential Hepatoprotective Effect of Matricaria Pubescens on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats. Chem Biodivers. 2024; 21(4):e202302005.
DOI: 10.1002/cbdv.202302005.
View
15.
Qu P, Rom O, Li K, Jia L, Gao X, Liu Z
. DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates. Cell Metab. 2023; 35(5):742-757.e10.
DOI: 10.1016/j.cmet.2023.03.013.
View
16.
Carvalho L, Dias B, Gomes S, Carneiro C, Caldeira Costa D
. Temporal effect of fructose supplementation at different concentrations on hepatic metabolism of Wistar rats. Nutr Hosp. 2021; 38(5):1089-1100.
DOI: 10.20960/nh.03691.
View
17.
Xu Y, Ke H, Li Y, Xie L, Su H, Xie J
. Malvidin-3--Glucoside from Blueberry Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Transcription Factor EB-Mediated Lysosomal Function and Activating the Nrf2/ARE Signaling Pathway. J Agric Food Chem. 2021; 69(16):4663-4673.
DOI: 10.1021/acs.jafc.0c06695.
View
18.
Dhami-Shah H, Vaidya R, Talwadekar M, Shaw E, Udipi S, Kolthur-Seetharam U
. Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells. J Ayurveda Integr Med. 2021; 12(3):465-473.
PMC: 8377190.
DOI: 10.1016/j.jaim.2021.04.007.
View
19.
Spooner M, Garcia-Jaramillo M, Apperson K, Lohr C, Jump D
. Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice. PLoS One. 2023; 18(10):e0292432.
PMC: 10566735.
DOI: 10.1371/journal.pone.0292432.
View
20.
Vazquez-Meza H, Vilchis-Landeros M, Vazquez-Carrada M, Uribe-Ramirez D, Matuz-Mares D
. Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies. Antioxidants (Basel). 2023; 12(4).
PMC: 10135322.
DOI: 10.3390/antiox12040834.
View